CLINICAL LEADERSHIP LIMITED

Company Registration Number:
09411820 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2026

Period of accounts

Start date: 1 April 2025

End date: 31 March 2026

CLINICAL LEADERSHIP LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2026

Directors report
Balance sheet
Additional notes
Balance sheet notes

CLINICAL LEADERSHIP LIMITED

Directors' report period ended 31 March 2026

The directors present their report with the financial statements of the company for the period ended 31 March 2026

Directors

The directors shown below have held office during the whole of the period from
1 April 2025 to 31 March 2026

Dr Lisa Jane Harrod-Rothwell
Mr Daniel Jonathan Rothwell


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
14 July 2026

And signed on behalf of the board by:
Name: Dr Lisa Jane Harrod-Rothwell
Status: Director

CLINICAL LEADERSHIP LIMITED

Balance sheet

As at 31 March 2026

Notes 2026 2025


£

£
Current assets
Cash at bank and in hand: 494 494
Total current assets: 494 494
Creditors: amounts falling due within one year: 3 ( 264 ) ( 54 )
Net current assets (liabilities): 230 440
Total assets less current liabilities: 230 440
Total net assets (liabilities): 230 440
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 228 438
Total Shareholders' funds: 230 440

The notes form part of these financial statements

CLINICAL LEADERSHIP LIMITED

Balance sheet statements

For the year ending 31 March 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 14 July 2026
and signed on behalf of the board by:

Name: Dr Lisa Jane Harrod-Rothwell
Status: Director

The notes form part of these financial statements

CLINICAL LEADERSHIP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CLINICAL LEADERSHIP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

  • 2. Employees

    2026 2025
    Average number of employees during the period 0 0

CLINICAL LEADERSHIP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

3. Creditors: amounts falling due within one year note

2026 2025
£ £
Accruals and deferred income 210
Other creditors 54 54
Total 264 54